Abstract Background: Patients with upper and lower airway symptoms and with pronounced sensitivity to chemical odours, such as perfumes, flower scents and tobacco smoke, have been suggested to have sensory hyperreactivity (SHR).The symptoms have been difficult to identify with physiological measurements and the effects of various medications are doubtful. However, these patients have been found to be more sensitive to inhalation of capsaicin than healthy people.The aim of this study was to establish limit values with the capsaicin inhalation test in patients with SHR. Methods: Ninety-five consecutive patients with upper and lower airway problems, who were admitted for allergy testing, underwent a capsaicin inhalation test with three different concentrations. The number of coughs was registered during each challenge. Score systems were used for symptoms and influence on sociallife of sensitivity to odours.In relation to scored symptoms, the patients were grouped as SHR or not, and compared with 73 healthy controls. Results: All patients and controls coughed on capsaicin in a dose-dependent manner. Symptom score of odour sensitivityin patients was positively correlated to the response ofthe test.Outof 95 patients,15 (16%) were scored to SHR.Patients with SHR reacted more to the capsaicin inhalation test than the other patients and the healthy controls 
INTRODUCTION
In daily clinical work at our Allergy Centre, we see patients with symptoms that do not ¢t the common diagnoses. One group of such patients with upper and lower airway complaints has pronounced sensitivity to various odours such as perfumes, cleaning agents, £ower scents, car exhaust fumes and tobacco smoke.These patients often have di⁄culty describing their symptoms, the most common being 'heavy breathing', 'di⁄cult in getting air', 'pressure across the chest' and 'blocked nose'. When lower airway symptoms predominate, the term 'asthma-like' has been used, but a main feature among those patients is the absence of bronchial obstruction (1) . The symptoms have been di⁄cult to identify with physiological measurements and the e¡ects of various medications are small or doubtful. The suggested mechanism behind these symptoms is a sensory hyperreactivity (SHR) (1) . SHR has a strong resemblance to multiple chemical sensitivity (MCS), the term used in American literature, which features symptoms from various organs including the airways and is caused by exposure to chemical substances (2^5). There are no objective methods to demonstrate MCS, considered to be a psychogenic disorder (6) .
In previous provocation tests, we found that patients with odour sensitivity complained at provocation with perfume, even when they were unable to smell it, which contraindicates a purely olfactory stimulation (7, 8) . Patients with odour sensitivity react more strongly with cough than do healthy individuals and asthmatics to provocation with capasaicin inhalation (1) . The capsaicin inhalation is an objective test, as has been demonstrated in a controlled study (9) . The induced cough can be blocked by local anaesthetics (9) , which supports the hypothesis that chemical stimulation of sensory nerve endings, probably the C-¢bres of the trigeminal nerve (10) are involved.The receptor for capsaicin,VR-1, binds capsaicin and other vanilloids, but other substances may also activate it (10, 11) . Stimulation of this receptor could serve to explain the problems of patients with odour sensitivity. Sensitivity to capsaicin varies among both healthy and sick individuals and is directly related to the degree of odour sensitivity (12) . The objectives of the present study were to establish limit values for the capsaicin inhalation test.
MATERIAL AND METHODS

Patients
All adult patients presenting with airway problems who were referred to the Allergy Centre in Sk˛vde during a period of 1 year were included in the study. Exclusion criteria were pregnancy and communication di⁄culties. The latter included both long travelling distance (more than 1h travelling time) and communication problems due to language and/or mental state. A total of 143 patients were presented at the Centre during the above period. Of these, 14 patients were excluded due to communication di⁄culties. By oversight, 3 patients were never asked whether they wanted to take part in the study and were consequently excluded. Therefore, 126 patientsF58 men and 68 womenFwere asked whether they were willing to participate in the study. Of these, 27 patients declined, representing a non-response of 21%. Consequently, 99 patients were studied, 44 men and 51 women between the ages of 18 and 73, with an average age of 34 and 36, respectively.They presented various airway symptoms, schematised inTable 1.
All patients were examined with anamneses, an allergy questionnaire, a skin prick test (sometimes in combination with analysis of speci¢c IgE in serum) and a clinical status. Spirometry and methacholine tests were performed in suspected asthma. An evaluation was made of patients' sensitivity to smelling chemical substances, such as perfumes, cleaning agents, £ower scents, tobacco smoke and car exhaust fumes, on a scale of 0^3 (0 = no sensitivity; 1 = mild sensitivity; 2 = moderate sensitivity; and 3 = strong sensitivity) for the upper respiratory airways including the larynx and the lower airways. The maximum score was 6 and the minimum was 0 point. In addition, an evaluation was made in order to determine social e¡ects of sensitivity to odorous substances. The patients were thus classi¢ed into ¢ve categories: 0 = no social e¡ects; 1 = occasional problems at home, at leisure and at the workplace; 2 = daily problems at work; 3 = intermittent sick leave; and 4 = long-term sick leave or disability pension. The results of allergy tests, the diagnosis and the patients' sensitivity to odours are presented in Table 1 . One patient had simple chronic bronchitis, and one chronic sinusitis. Three patients had re£ux esophagitis: of these, two were smokers. One patient used an angiotensin II-blocker, and no patients were taking ACE-inhibitors of b-blockers. The controls comprised 73 non-smoking, subjectively healthy volunteers (42 women and 31 men, 17^72 years of age, mean 41 years). The capsaicin test was performed on all patients and healthy controls. 
The capsaicin inhalation test
The test was initiated with inhalation of1ml of normal saline for 6 min, followed by 4 min of rest, as previously described (1). The provocation was not administered during an acute respiratory air infection. For inhalation, a nebuliser was used (Pariboy 36, Paulritzau Pari-werk KG, Starnberg-am-See, Germany). The number of coughs was registered with a tape recorder and counted for 10 min from the start of provocation. Thereafter, the subject was provoked in the same manner with increasing concentrations of capsaicinF0.4, 2.0 and 10 mM in a1ml solution. If a subject responded with X70 coughs during one dose, no more capsaicin was administered; however, the counting of coughs continued for 10 min. The limit of 70 coughs to abolish the inhalation of capsaicin was set according to previous experience of what a subject could bear.
Statistics
The cough responses to each dose of capsaicin were compared by paired t-test after a logarithmic transposition. The relation between patient symptom score and number of coughs after capsaicin inhalation test was analysed by linear regression. In comparing patients and healthy controls, a 95% con¢dence interval (CI) was used and the limit for a pathological response to the capsaicin inhalation test was determined. To investigate possible confounders for SHR, a multiple logistic regression was ¢tted to the data. The following explanatory variables were selected in this model: age, sex, presence of asthma and rhinitis, sensitivity to cold air, smoking, and interactions of these variables. To keep this model as parsimonious and plausible as possible, stepwise selection (forward and backward) procedures were used. The signi¢cance level for entry and removal of a variable was set to 5%.
RESULTS
One patient started the provocation with normal saline but was afraid to continue with capsaicin, and three individuals were afraid to undergo the provocation with the highest dose. Therefore, 95 patients were taken through the entire protocol. All controls passed the test. The test itself was harmless and well tolerated, and no serious side-e¡ects were registered.
Both patients and controls coughed more with increasing doses of capsaicin, and there was a statistically signi¢cant dose^response relationship for the capsaicin provocation at each dose with a P-value of at least o0.001. The e¡ect of capsaicin in the patients by the 2.0 mM capsaicin provocation is shown in Fig. 1 . The biphasic appearance indicates that this population consists of two subgroups, one of which seems to be more sensitive to capsaicin than the majority.
There was a direct relationship between the number of coughs and the symptom score of sensitivity to odours (correlation coe⁄cient r 2 = 0.34, Po0.0001, capsaicin 2.0 mM). Out of 95 patients, 60 (63%) reported any sensitivity to odours. Patients who exhibited pronounced symptoms, here identi¢ed with a total upper and lower airway symptom score of at least 4, were diagnosed with SHR. In total,15 patients (11women and 4 men, mean age 42 years old) ful¢lled this criteria. The e¡ect of the capsaicin provocation test was then compared between three groups: patients with SHR, patients without SHR and healthy controls ( Table 2) . Patients with SHR coughed signi¢cantly more on capsaicin than the other groups. By studying the mean capsaicin response and the CIs in Table 2 for the healthy controls and patients, the cut-o¡ values for SHR could be approximately 10, 35 and 55 coughs for 0.4, 2.0 and 10 mM capsaicin, respectively (Fig. 2) . SHR was related to gender (females), rhinitis and lower airway sensitivity to cold air, but not to age, asthma or smoking.
DISCUSSION
Upper and lower airway complaints from contact with various chemical substances, such as perfumes, cleaning agents, £ower scents, car exhaust fumes and tobacco smoke, are common among patients with airway problems who are referred to the Allergy Centre. Epidemiological studies are needed to establish the frequency of this condition in the general population (to be published). In this study, we established three limit values for the capsaicin inhalation test for patients with pronounced sensitivity to odours and symptoms in the upper and lower airways. These patients constitute a clinical population in an allergy centre, thus their symptoms varied greatly. It is necessary to develop a more sophisticated questionnaire to identify patients with SHR, one with a combined score of symptoms and social restrictions related to sensitivity to odours.
A study model designed to illustrate the variety of symptoms in large patient groups should be simple and should not require a great deal of time or resources. We feel that our way of carrying out the capsaicin inhalation test meets these requirements and the method has shown good reproducibility (1) . We chose to use a common inhalation apparatus that was loaded with a small amount of liquid (1ml). This produced a large number of particles 45 mM, meaning that a smaller amount of particles dispersed peripherally (13) . The limit values that were obtained for a positive capsaicin inhalation test depend on this design and cannot be used directly for inhalation with another inhaler or with di¡erent amounts of liquid. In future, it might be possible to use only one concentration of capsaicin. In performing the capsaicin inhalation, saline and lowest dose of capsaicin are likely to be of key importance for training the patient. Discomfort with the capsaicin inhalation may cause patients to change the way they inhale.Certain individuals can avoid coughing to a certain extent, but with a higher concentration the cough re£ex becomes irresistible. Therefore, even a low, less irritating dose may be of value for the test.
The degree of sensitivity to capsaicin was positively related to the symptoms induced by chemicals and odours. It must be emphasised that the inhalation test is non-speci¢c, as other patient groups have also shown increased sensitivity to capsaicin (14^18). However, among patients with airway problems who were admitted for allergy exams, we could identify a group of individuals who claimed to be distinctly sensitive to chemical substances such as perfumes, £ower scents and tobacco smoke. After provocation of all patients and healthy controls with inhalation of capsaicin, we established limit values for a positive capsaicin inhalation test for patients with SHR. The capsaicin inhalation test is not harmful and can be administered safely to patients with airway problems.
FIG. 2.
The mean number of coughs (7SEM) after provocation with saline and three doses of capsaicin in patients with SHR (¢lled circles, n = 15), and others patients without SHR (n = 80) and non-smoking healthy subjects (squares, n = 73).The dotted line represents the upper limit for a normal capsaicin inhalation test. 
